Prominent regression of corneal deposits in Fabry disease 16 years after initiation of enzyme replacement therapy.

MLA

Koh, Shizuka, et al. “Prominent Regression of Corneal Deposits in Fabry Disease 16 Years after Initiation of Enzyme Replacement Therapy.” Acta Ophthalmologica, vol. 96, no. 2, Mar. 2018, pp. e255–56. EBSCOhost, https://doi.org/10.1111/aos.13541.

APA

Koh, S., Sakai, N., Maeda, N., & Nishida, K. (2018). Prominent regression of corneal deposits in Fabry disease 16 years after initiation of enzyme replacement therapy. Acta Ophthalmologica, 96(2), e255–e256. https://doi.org/10.1111/aos.13541

Chicago

Koh, Shizuka, Norio Sakai, Naoyuki Maeda, and Kohji Nishida. 2018. “Prominent Regression of Corneal Deposits in Fabry Disease 16 Years after Initiation of Enzyme Replacement Therapy.” Acta Ophthalmologica 96 (2): e255–56. doi:10.1111/aos.13541.